Who we are and what we do

image

Who

We are a group of experienced drug development specialists offering deep, disruptive & transformative expertise in accelerating clinical research pathways for innovative, modern age therapeutics.

What

Dimension-T, our unique, subscription based solution allows early stage biotech companies to efficiently strategize, plan and execute clinical development programs.

How

We bridge the gap between science and patients by applying agile clinical, regulatory and project management disciplines.
knowlege image

WHY WE DO WHAT WE DO

WHY WE DO WHAT WE DO

Modern innovations, such as CGT (Cell & gene therapy), have the potential to deliver transformative, if not curative, treatments for cancer and other diseases

OUR PURPOSE - PATIENTS CAN’T WAIT!

OUR PURPOSE - PATIENTS CAN’T WAIT!

Emerging biotechs deserve a contemporaneous clinical development model, offering acceleration and scalability; which we are positioned to deliver with our proprietary solution Dimension-T

A pioneering yet simple to adopt (minimalistic) approach to designing & executing drug development program

image Subscription offering strategic & niche talent, aptly designed digital technology suite & predefined business processes

image Creates immediate & accentuated long term time value inflection taking “clinical execution” off the critical path

image Deeply rooted in enriching patient experience in trials; translating the learnings to commercial positioning

image Pan Portfolio synergies create intrinsic and undiscovered value for biotech companies and their investors

WHY CHOOSE US ?

188

Years Of Drug Development Experience

299

Clinical Trials Experience

148

Products Experience

17

Therapeutic Areas Across Oncology and Pharma

Ubuntu developed a subscription-based CGT Dimension-T model

Ubuntu has diligently crafted a ‘fit for purpose’ operating model specifically around following value creation levers
Cost & Time Efficiency

Resources required to establish a functional clinical team and rapidly achieve key developmental milestones

Platform Approach

Dedicated vs communal stack based on build once, integrate learnings and reuse

Operational Risk

Execution risks are insufficiently characterized, play a critical role in realizing outcomes

Patient Centricity:

Product development strategy devised around personalized treatment plans, broad inclusivity & well informed clinical trial engagement

image
image